Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017:2017:6408956.
doi: 10.1155/2017/6408956. Epub 2017 Feb 20.

Anesthetic Considerations in a Patient with Myotonic Dystrophy for Hip Labral Repair

Ramon Go  1 , David Wang  1 , Danielle Ludwin  1
Affiliations
Case Reports

Anesthetic Considerations in a Patient with Myotonic Dystrophy for Hip Labral Repair

Ramon Go et al. Case Rep Anesthesiol. 2017.

Abstract

Myotonic Dystrophy (DM) affects multiple organ systems. Disorders such as hyperthyroidism, progressive musculoskeletal weakness, cardiac dysrhythmias, hypoventilation, and cognitive-behavioral disorders may be present in these patients. Thorough preoperative assessment and anesthetic planning are required to minimize the risk of anesthetic complications. Patients with DM can exhibit exquisite sensitivity to sedatives, neuromuscular blocking agents, and volatile anesthetics, resulting in potential postoperative complications. There is limited literature available on successful anesthetic techniques for the DM patient. We present this case report to add to our current fund of knowledge.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Zhou J. Neuromuscular disorders and malignant. In: Miller R. D., editor. Miller's Anesthesia. 7th. Philadelphia, Pa, USA: Churchill Livingstone/Elsevier; 2010. pp. 1181–1195.
    1. Toth C., Dunham C., Suchowersky O., Parboosingh J., Brownell K. Unusual clinical, laboratory, and muscle histopathological findings in a family with myotonic dystrophy type 2. Muscle and Nerve. 2007;35(2):259–264. doi: 10.1002/mus.20685. - DOI - PubMed
    1. Bianchi M. L. A. E., Losurdo A., Di Blasi C., et al. Prevalence and clinical correlates of sleep disordered breathing in myotonic dystrophy types 1 and 2. Sleep & Breathing. 2014;18(3):579–589. doi: 10.1007/s11325-013-0921-5. - DOI - PubMed
    1. Lee F. I., Hughes D. T. D. Systemic effects in dystrophia myotonica. Brain. 1964;87(3):521–536. doi: 10.1093/brain/87.3.521. - DOI - PubMed
    1. Mathieu J., Allard P., Potvin L., Prévost C., Begin P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology. 1999;52(8):1658–1662. doi: 10.1212/wnl.52.8.1658. - DOI - PubMed

Publication types

LinkOut - more resources